Risk of neurodevelopmental abnormalities in children treated with propranolol

Br J Dermatol. 2015 Dec;173(6):1562-4. doi: 10.1111/bjd.14000. Epub 2015 Oct 28.

Authors

C Labrèze¹, J-J Voisard², A Delarue², N Moore³

Affiliations

¹ Pediatric Dermatology Unit, Pellegrin Children's Hospital, Place Amélie Raba-Leon, Bordeaux, 33076, France. christine.labreze@chu-bordeaux.fr.
² Pierre Fabre Dermatologie, Lavaur, France.
³ Departement de Pharmacologie, Université de Bordeaux, Bordeaux, France.

PMID: 26135132
DOI: 10.1111/bjd.14000

No abstract available

Publication types

Letter

MeSH terms

Adrenergic beta-Antagonists / adverse effects*
Animals
Child, Preschool
Female
Hemangioma / drug therapy*
Humans
Infant
Male
Neurodevelopmental Disorders / chemically induced*
Propranolol / adverse effects*
Rats, Sprague-Dawley

Substances

Adrenergic beta-Antagonists
Propranolol